Sage Therapeutics :
SAGE
SAGE
Stock Data
$8.68
$0.00 (0.00%)
Asset Type
N/A
Exchange
N/A
Currency
N/A
Country
N/A
Sector
N/A
Industry
N/A
Sage Therapeutics Inc is a biopharmaceutical company focused on innovating brain health medicines. It has developed ZULRESSO, a treatment for postpartum depression, and is working on other promising drugs like ZURZUVAE for the same condition, SAGE-324 for essential tremors, and SAGE-718 aimed at various neurological disorders including depression and Alzheimer's disease. The company collaborates with global partners like Shionogi & Co. and Biogen MA Inc. to expand its reach. Founded in 2010 and based in Cambridge, Massachusetts, Sage Therapeutics is committed to addressing unmet needs in brain health.
All Sage Therapeutics Articles
18 Articles